Drugmaker Parabilis Soars 67% After $745 Million IPO, Placement

Parabilis Medicines Inc. shares jumped as much as 67% in its trading debut, after the company raised nearly $745 million in an upsized US initial public offering that priced above its marketed range and a private placement.